Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Weighty Issues: GW Obesity Outcomes Project Tests Model For Patient Input In Drug Development

May 14 2012

• By Michael McCaughan

Related Content

FDA and the R&D Crisis: Time to Stop the Blame Game

Jul 01 2011

FDA Rethinking Weight Loss Standards: A Test Case for Patient-Focused Drug Development

Jun 06 2011

Lorcaserin Makes It Past Panel On The Strength Of Effect In Some Patients

May 14 2012

Setting the Stage: <em>Qnexa</em> and the Power of REMS

Mar 01 2012

The Inevitable Outcome: Diabetes Safety Model Expands to Weight Loss…and Beyond?

May 01 2012

FDA Pressed At <i>Meridia</i> Committee Review To Finalize Obesity Drug Guidance

Sep 20 2010

FDA's Patient-Centered Drug Center

Dec 15 2011

Related Companies

Vivus, Inc.

Arena Pharmaceuticals, Inc.

George Washington University

Orexigen Therapeutics, Inc.

Sanofi

Allergan plc

Additional Topics

Clinical Trials Drug Approval Standards BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window